1.
Philip Saunders, Adam Cisterne, Jocelyn Weiss, Kenneth F. Bradstock, Linda J. Bendall. The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia. Haematologica 2010;96(1):69-77; https://doi.org/10.3324/haematol.2010.026997.